Archived — published Apr 23, 2026
💪Fitness & Sports
Daraxonrasib, thérapie ciblée doublant la survie du cancer du pancréas
60/ 100declining
FR Apr 23, 2026
FR Apr 23, 2026Trend Signal
Mentions trend ✨ New
30j7jNow
6
mentions (7d)
6
mentions (30d)
Apr 23, 2026
first seen
1
countries
Context & Analysis
This trend "Daraxonrasib, thérapie ciblée doublant la survie du cancer du pancréas" was detected in the Fitness & Sports category with a score of 60/100. This trend is showing signs of slowdown after a period of interest.
Related entities
https://www.elsan.care/fr/nos-actualites/nouveau-traitement-cancer-pancreas-daraxonrasibhttps://www.futura-sciences.com/sante/actualites/cancer-pancreas-espoir-majeur-cancer-pancreas-nouveau-traitement-double-survie-patients-an-133829/cross:sante
Related Article
Daraxonrasib, thérapie ciblée doublant la survie du cancer du pancréasRelevance: 100%